Koco McAboy takes us to downtown LA to preview Lucha VaVoom de La Liz at the Mayan Theatre. Two separate incidents at Men's Central Jail Tuesday caused seven inmates and seven deputies to be ...

CAMBRIDGE, MA / ACCESSWIRE / October 31, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced its participation in the following upcoming investor conferences: Guggenheim's Inaugural Healthcare ...

On Monday, Merck & Co Inc (NYSE:MRK) and Moderna, Inc. (NASDAQ:MRNA) announced the initiation of INTerpath-009, a pivotal Phase 3 trial of V940 (mRNA-4157). V940 is an investigational ...

Almost every scene of the powerful "La Cocina" takes place in or just outside the kitchen of a Times Square tourist trap bluntly dubbed The Grill. It's one of those places that does a bit of ...

Taco Bell is going retro starting in November. The fast-food restaurant announced Thursday that they are reviving the five most demanded nostalgia items from its first 50 years on a Decades Menu.

The Tostada is the most dated item. It was one of the six items released at Taco Bell’s first walkup location in California, per a press release, and tops a tostada shell with refried beans ...

Moderna, Inc.'s share price has weakened due to declining COVID-19 vaccine demand, but its diverse asset portfolio supports future growth and returns. The company is focusing on respiratory ...

The 2024 League of Legends World Championship is slowly coming to an end, with the final playoffs matches left to determine this year’s winners. While many players are following the competitive ...

This time, we have GSK (GSK) "GSK" filing a lawsuit against Moderna (NASDAQ:MRNA) accusing them of patent infringement on their lipid nanoparticle (LNP) technology, which is used in mRNA therapeutics.

Tyler Van Buren’s rating is based on several factors influencing Moderna’s financial outlook. The analyst has adjusted the company’s expense projections downward, reflecting a more ...

At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II, randomised, observer-blind, placebo-controlled, dose-ranging trial (NCT05992935) for mRNA-1403, a prophylactic vaccine ...

To date, no vaccines that protect NoV have been licensed. Credit: Novikov Aleksey via Shutterstock. At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II, randomised, ...